Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 9,321 | 12,964 | 988 | 10,832 | 11,580 |
Short-term investment |
| 0 | 49 | 0 | 0 | 1,801 |
Accounts receivables |
| 1,708 | 1,470 | 1,205 | 998 | 2,156 |
Inventories |
| 4,258 | 5,002 | 4,865 | 4,830 | 5,467 |
Deferred income taxes |
| 1,525 | 3,021 | 0 | 3,098 | 0 |
Other current assets |
| 1,455 | 2,379 | 13,004 | 1,088 | 1,023 |
Total current assets |
| 18,267 | 24,885 | 20,061 | 20,847 | 22,027 |
Gross property plant... |
| 2,527 | 2,501 | 13,671 | 6,676 | 3,096 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 2,527 | 2,501 | 13,671 | 6,676 | 3,096 |
Work in Progress |
| 5,732 | 9,229 | 0 | 1,201 | 132 |
Miscellaneous Investment |
| 191 | 171 | 0 | 162 | 134 |
Deferred income taxes |
| 916 | 1,037 | 622 | 1,105 | 4,496 |
Intangible assets |
| 322 | 727 | 655 | 496 | 434 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 2,082 | 924 | 4,103 | 868 | 814 |
Total non-current assets |
| 11,771 | 14,590 | 19,052 | 10,509 | 9,107 |
Total assets |
| 30,038 | 39,475 | 39,113 | 31,355 | 31,134 |
Short-term debt |
| 0 | 0 | 4 | 0 | 0 |
Accounts Payable... |
| 2,789 | 5,059 | 4,825 | 3,576 | 4,645 |
Provisions |
| 487 | 976 | 0 | 2,768 | 2,542 |
Taxes Payable |
| 21 | 1,541 | 1,534 | 1,614 | 1,637 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 148 | 144 |
Other current liabilities |
| 3,905 | 8,424 | 8,179 | 2,136 | 4,358 |
Total current liabilities |
| 7,202 | 15,999 | 14,543 | 10,243 | 13,325 |
Long-term debt |
| 10 | 6 | 2 | 0.24 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 0 | 0 | 0 | 0 | 0 |
Provisions |
| 2,723 | 2,874 | 0 | 2,617 | 2,595 |
Capital Leases |
| 0 | 0 | 0 | 268 | 202 |
Other longterm liabilities |
| 35 | 23 | 3,170 | 21 | 21 |
Total non-current liabilities |
| 2,767 | 2,903 | 3,172 | 2,907 | 2,818 |
Total liabilities |
| 9,970 | 18,902 | 17,715 | 13,149 | 16,143 |
Share Capital |
| 847 | 847 | 1,694 | 1,694 | 1,694 |
Share premium |
| 0 | 0 | 26 | 0 | 0 |
Retained earnings |
| 19,222 | 19,726 | 11,876 | 16,512 | 13,297 |
Accumulated other equity |
| 0 | 0 | 7,802 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 20,069 | 20,573 | 21,398 | 18,206 | 14,991 |
Total Liabilities and Equity |
| 30,038 | 39,475 | 39,113 | 31,355 | 31,134 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |